Tony Musu

Senior Researcher


Tony Musu gained a first degree in Chemical Engineering from the University of Brussels and a PhD in from the Institut Pasteur in Paris. After his PhD, he spent 5 years as a researcher in industry dealing with the safety assessment of chemicals. Since 2003, he has been working as researcher in the ETUI’s Health and Safety Department. On behalf of the ETUC, he takes part in various REACH-related EU working groups and he was a Board member of the European Chemicals Agency (ECHA) in the period 2007-2012. He is also a member of the Ad Hoc WG on Chemicals within the Luxembourg Advisory Committee on Health & Safety at work.

Areas of activity

REACH, chemicals, worker protection legislations, nanotechnologies, Risctox database.

Search on Labourline for more publications from this author

Publications from this author

See all
Pierre Bérastégui, Stan De Spiegelaere, Christophe Degryse, ...

Benchmarking Working Europe 2020

→ A virus is haunting Europe. And it could strike again. This year’s 20th anniversary issue of our flagship publication Benchmarking Working Europe brings to a growing audience of trade unionists, industrial relations specialists and policymakers a simple warning: beside SARS-CoV-2, the virus that has caused the Covid-19... Find out more

Cancer and work: understanding occupational cancers and taking action to eliminate them

Occupational cancers account for more than 100,000 deaths a year in the EU, yet these could be avoided by eliminating carcinogens in the production processes. This edited volume brings together the contributions of 28 experts for a review of the current state of knowledge on the issue, new prevention practices, the evolution of legislation and the... Find out more

Marie-Anne Mengeot, Tony Musu, Laurent Vogel

Endocrine disruptors: an occupational risk in need of recognition

This guide, which received the 2018 Prescrire Prize, is intended for representatives (in particular those on health and safety committees) of workers potentially exposed to endocrine disruptors at work. It takes stock of research findings on the health consequences of workers being exposed to chemical substances with potentially harmful effects on... Find out more

Tony Musu, Laurent Vogel, Henning Wriedt

Cancer risks in the workplace: better regulation, stronger protection

In the context of the announced revision of the directive on carcinogenic substances, this publication reviews the limitations of the existing legislation and outlines the priorities for its reform.It considers the key aspects of this issue: the setting of threshold limit values for workplace exposure the risks these substances pose to reproduction... Find out more